2012
DOI: 10.1080/17513758.2012.678392
|View full text |Cite
|
Sign up to set email alerts
|

Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols

Abstract: A practical mathematical model for glioblastomas (brain tumours), which incorporates the two key parameters of tumour growth, namely the cancer cell diffusion and the cell proliferation rate, has been shown to be clinically useful and predictive. Previous studies explain why multifocal recurrence is inevitable and show how various treatment scenarios have been incorporated in the model. In most tumours, it is not known when the cancer started. Based on patient in vivo parameters, obtained from two brain scans,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 22 publications
0
19
0
Order By: Relevance
“…Both of them are increasingly being used for treatment of human brain tumors [25,26]. Value of cell proliferation rate has been taken for human brain tumors (glioblastoma) [27]. Pharmacokinetic parameters of LED and free drug and their AIF were taken from literature and are listed in Table 1.…”
Section: Pharmacodynamics Modelmentioning
confidence: 99%
“…Both of them are increasingly being used for treatment of human brain tumors [25,26]. Value of cell proliferation rate has been taken for human brain tumors (glioblastoma) [27]. Pharmacokinetic parameters of LED and free drug and their AIF were taken from literature and are listed in Table 1.…”
Section: Pharmacodynamics Modelmentioning
confidence: 99%
“…66 Setting f (c (x,t)) = ⋅ c (x,t), a similar model structure was also used to simulate the growth of glioblastoma based on previous reported parameters estimated from patients and estimated the survival times of patients under different parameter settings. 67 Likewise, the proliferation-invasion model with logistic growth function was also successfully applied in breast cancer patients to characterize and predict their tumor burden. 68 The model developed based on MRI data that were available from the early treatment phase was demonstrated to be able to predict patient response at the end of treatment.…”
Section: Tumor Dynamics and Resistance Evolution Modelsmentioning
confidence: 99%
“…35, where k d is the drug effect rate constant. 67 For radiotherapy, a linear-quadratic equation has been used to estimate the probability of tumor cell survival (Surv) after the administration of radiation with dose Dose (Eq. 36).…”
Section: Tumor Dynamics and Resistance Evolution Modelsmentioning
confidence: 99%
“…With this solution we can given the density of cancer cells in every point of (r, τ) ∈ (0, 1]×[0, 1]. In figure 4, we can observe the approximate-linear tumour growth-profile after the patient is under chemotherapy treatment with Temozolomide in contrast with the fast exponential growth given by (15) and corresponding to free-growth tumour. The free-growth tumour profile was shown in [7], in which the value of η(r,t) is given for different values of the parameters D, p and k(t) = 0.…”
Section: Solution Of a Nonlinear Modelmentioning
confidence: 99%
“…In order to see the effect of medical treatment, we can compare the radius of the tumour under medical treatment versus the radius of the untreated tumour. Using the solution (15) of the Burgess linear partial equation and solving for r (also see [15]) that accounts for free growth of an untreated tumour , we obtain…”
Section: Solution Of a Nonlinear Modelmentioning
confidence: 99%